In recent years, Lake Whillans has published extensively on the multifaceted interplay between the legal market and the life sciences industry, specifically identifying the most active and relevant law firms for life science companies. This year, Lake Whillans is flipping the telescope around with the publication of The 10 Most Innovative Life Sciences Deals of 2017. Rather than focusing on the firms involved, this feature highlights those transactions best exemplifying some of the most significant emerging trends in the life sciences and biotech space. Our list includes transactions concerning new market opportunities, contract research organizations, precision medicine, the digital-pharma convergence, and an array of other hot topics in the sector. Check out the full list here.
The life sciences are among the very few industries where companies insist on industry-specialized advisors. This holds true not only for legal counsel, but for all potential partners who can help protect innovators’ interests at every stage of the product life cycle. Such partners can–in the case of an unforeseen setback or conflict– include litigation financiers. Thus Lake Whillans’ preeminent technical expertise on the litigation finance side is informed by deep industry-specific research and insight. Should an innovative company or entrepreneurial litigator need help with a meritorious claim, Lake Whillans is there to step in.
